Log in
A+ A A-

An "Important" Reduction in Risk of Stent Thrombosis with Everolimus-eluting Stent: Results from the Bern-Rotterdam Cohort Study

Hot Line III - Acute Coronary Syndromes Topics: Percutaneous Cardiovascular Intervention (PCI)

Paris, France, 30 August: Results of the independently-funded Bern-Rotterdam cohort study provide robust evidence of an "important" reduction in overall and very late stent thrombosis. The reduction in incidence was found when a newer generation everolimus-eluting stent (EES) was compared with early generation drug-eluting stents (DES) at long-term follow-up.

"The near elimination of stent thrombosis observed between one and four years after implantation shows that everolimus-eluting stents overcome the principal limitation of early generation DES," said investigator Dr Lorenz Räber from the University Hospital of Bern, Switzerland. "This an important advance in the safety of DES."

Subscribe to this RSS feed


New York


Humidity: 20%

Wind: 7 mph

  • 5 Apr 2016 43°F 29°F
  • 6 Apr 2016 49°F 44°F